Prostate Cancer Clinical Trials
The latest clinical trials for patients with all stages of prostate cancer.
Any cancer diagnosis can be overwhelming. If you’ve been diagnosed with prostate cancer, you want to know you’re receiving the best available care. At the Henry Ford Cancer Institute, our expert team offers the latest treatment, including prostate cancer clinical trials.
Through clinical trials and other research, our specialists have helped to pioneer advanced procedures, such as minimally invasive robotic surgery, cryotherapy, radiation therapy and other treatments.
Our team can help you decide if you want to pursue a clinical trial and if there’s a trial that’s a good fit for you.
Clinical trials for prostate cancer diagnosis and treatment
At any time, we offer up to 20 clinical trials for prostate cancer. We’re investigating a variety of methods, with a focus on using existing therapy in new ways, exploring new diagnostic techniques, and identifying new drugs. This includes:
- Focal therapy and local treatment for prostate cancer
- Genomic testing of biopsied tissue to determine treatment planning for men with low-grade prostate cancer
- New therapies for metastatic prostate cancer
See all our open clinical trials for prostate cancer.
How prostate cancer clinical trials work
Prostate cancer trials proceed through phases. First, we determine if the approach is safe. Then we evaluate if it’s effective and works better than existing options.
The goal of a clinical trial is to gain approval for a new diagnostic technique or treatment that will help as many people as possible. Participating in trials can give you early access to promising therapies. Assuming you’re eligible, joining a trial is voluntary and always your decision.
Clinical trials must follow strict guidelines set ahead of time and made clear to participants. They are approved and overseen by an Institutional Review Board (IRB), made up of doctors, scientists, statisticians and laypeople. The board ensures a reasonable balance between expected risk and benefit.
Participating in a prostate cancer clinical trial
To ensure the safety of participants and the usefulness of collected data, eligibility guidelines vary from trial to trial. Not everyone qualifies for a clinical trial.
Your Henry Ford prostate cancer team works with you and your loved ones to determine if you might benefit from a clinical trial and wish to participate. Team members will explain the process further, including the potential risks and benefits.